How does finasteride (a 5‑alpha‑reductase type II inhibitor) work for androgenetic alopecia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How Finasteride Works for Hair Loss

Finasteride blocks the enzyme Type II 5α-reductase, which normally converts testosterone into dihydrotestosterone (DHT) in hair follicles, thereby reducing DHT levels by approximately 70% and preventing the progressive miniaturization of scalp hair follicles that causes male pattern baldness 1.

Mechanism of Action

Finasteride is a competitive and specific inhibitor of Type II 5α-reductase, the enzyme responsible for converting testosterone to DHT in the prostate, liver, and skin 1. Here's how it works step-by-step:

  • DHT is the culprit: DHT binds to androgen receptors in hair follicle cells and causes progressive shrinking (miniaturization) of genetically susceptible follicles, leading to thinner, shorter hairs until follicles eventually stop producing visible hair 2

  • Finasteride blocks DHT production: By inhibiting Type II 5α-reductase, finasteride forms an extremely stable enzyme complex with a turnover half-life of approximately 30 days 1. This results in:

    • ~70% reduction in serum DHT with daily 5 mg dosing 1
    • ~50% reduction in serum DHT with the 1 mg dose used for hair loss 1
    • Maximum DHT suppression occurs 8 hours after dosing and is maintained throughout the 24-hour interval 1
  • Testosterone levels slightly increase: As less testosterone is converted to DHT, circulating testosterone levels rise by approximately 10-20%, but remain within normal physiological range 1

  • Hair follicles recover: With reduced DHT exposure, miniaturized follicles can gradually reverse their shrinkage and produce thicker, longer hairs again

Clinical Efficacy

The evidence demonstrates clear benefit:

  • Hair count increases significantly: Finasteride 1 mg/day increased total hair count by 12.4 hairs/cm² at 24 weeks and 16.4 hairs/cm² at 48 weeks compared to placebo 3

  • Patient-reported improvement: Men are 1.81 times more likely to report scalp hair improvement in the short term (≤12 months) and 1.71 times more likely in the long term (≥24 months) compared to placebo 4. The number needed to treat is 5.6 patients in the short term and 3.4 in the long term 4

  • Sustained benefit requires continued use: The therapeutic effect ends when treatment is discontinued, as DHT levels return to baseline and follicle miniaturization resumes 5

Important Caveats

Sexual side effects are the primary concern: Finasteride increases the risk of erectile dysfunction (2.22 times higher than placebo) and may increase overall sexual disturbances 4. The most commonly reported issues include:

  • Erectile dysfunction
  • Decreased libido
  • Decreased ejaculate volume 6

Post-finasteride syndrome: Some men report persistent sexual dysfunction, depression, and other symptoms that continue months to years after discontinuation 3, 7. This led the FDA to add depression warnings to the label in 2011 3. While these reports exist primarily as case series and have methodological limitations, they cannot be dismissed 8.

Reproductive effects: Recent evidence shows finasteride may reduce sperm count by 34%, decrease sperm concentration and motility, and alter hormonal profiles 7. Men of reproductive age should be counseled about these potential effects.

The sexual dysfunction paradox: While sexual side effects are statistically significant in trials, the magnitude is often small (mean difference of 3.21 points on a 0-100 scale) and decreases over time with continued use 6. Most sexual side effects resolve spontaneously even without discontinuing therapy 8. However, the risk of permanent effects in a subset of patients remains a serious consideration.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.